How can virus-like particles aid in developing antibodies against Nipah

- Virus-like particles (VLPs) mimic the structure of a virus without containing the genetic material, making them safe for use in research and vaccine development. - VLPs can be engineered to display specific antigens from the Nipah virus, stimulating an immune response and triggering the production of antibodies. - By presenting these antigens in a natural conformation, VLPs can induce a more targeted and effective immune response compared to traditional methods. - VLPs can serve as a versatile platform for studying virus-host interactions, antigen presentation, and immune responses, aiding in the design of vaccines and therapeutics against Nipah virus. - The use of VLPs offers a safer alternative to live virus vaccines and allows for more controlled experiments in studying Nipah virus infections.